Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jan;63(1):57–65. doi: 10.1128/iai.63.1.57-65.1995

Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities.

H Takada 1, Y Kawabata 1, R Arakaki 1, S Kusumoto 1, K Fukase 1, Y Suda 1, T Yoshimura 1, S Kokeguchi 1, K Kato 1, T Komuro 1, et al.
PMCID: PMC172957  PMID: 7806384

Abstract

Comparison was made between the immunobiological and antigenic properties of two lipoteichoic acid (LTA) fractions (LTA-1 and -2) from Enterococcus hirae ATCC 9790, their glycolipid portions, and synthetic compounds partially mimicking the above bacterial products. The more lipophilic LTA-2 fraction was capable of inducing serum tumor necrosis factor alpha and interleukin-6 in muramyldipeptide-primed mice and serum gamma interferon in those primed with Propionibacterium acnes. The LTA-2 fraction also induced tumor necrosis factor alpha, interleukin-6, and thymocyte-activating factor (essentially interleukin-1) in murine peritoneal macrophage cultures. Consecutive intravenous injections of muramyldipeptide and the LTA-2 fraction in Meth A fibrosarcoma-bearing BALB/c mice caused hemorrhagic necrosis and marked regression leading to complete regression of the tumor with no accompanying weakening or lethal effects. The LTA-2 fraction was at least 10,000-fold less pyrogenic in rabbits than a reference endotoxic lipopolysaccharide. The more hydrophilic LTA-1 fraction, on the other hand, showed at most marginal activity in the in vivo and in vitro assays. Natural glycolipids (NGL-1 and -2) which were prepared from a chloroform-methanol extract of Streptococcus pyogenes and E. hirae cells, and comparable in structure to the lipid moieties of the LTA-1 and -2 fractions, respectively, were practically inactive in all of the assays. None of the test synthetic compounds was immunobiologically active, although synthetic partial counterparts of the structure of LTA proposed by W. Fischer (Handb. Lipid Res. 6:123-234, 1990) reacted with murine monoclonal antibody TS-2, which was raised against OK-432, a penicillin-killed S. pyogenes preparation, and capable of neutralizing the cytokine-inducing activities of the LTA-2 fraction.

Full Text

The Full Text of this article is available as a PDF (302.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  2. Bhakdi S., Klonisch T., Nuber P., Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun. 1991 Dec;59(12):4614–4620. doi: 10.1128/iai.59.12.4614-4620.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brade L., Brade H., Fischer W. A 28 kDa protein of normal mouse serum binds lipopolysaccharides of gram-negative and lipoteichoic acids of gram-positive bacteria. Microb Pathog. 1990 Nov;9(5):355–362. doi: 10.1016/0882-4010(90)90069-3. [DOI] [PubMed] [Google Scholar]
  4. Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666–3670. doi: 10.1073/pnas.72.9.3666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dziarski R., Gupta D. Heparin, sulfated heparinoids, and lipoteichoic acids bind to the 70-kDa peptidoglycan/lipopolysaccharide receptor protein on lymphocytes. J Biol Chem. 1994 Jan 21;269(3):2100–2110. [PubMed] [Google Scholar]
  6. Fischer W., Koch H. U., Haas R. Improved preparation of lipoteichoic acids. Eur J Biochem. 1983 Jul 1;133(3):523–530. doi: 10.1111/j.1432-1033.1983.tb07495.x. [DOI] [PubMed] [Google Scholar]
  7. Fischer W., Nakano M., Laine R. A., Bohrer W. On the relationship between glycerophosphoglycolipids and lipoteichoic acids in Gram-positive bacteria. I. The occurrence of phosphoglycolipids. Biochim Biophys Acta. 1978 Mar 30;528(3):288–297. doi: 10.1016/0005-2760(78)90018-8. [DOI] [PubMed] [Google Scholar]
  8. Galanos C., Lüderitz O., Westphal O. Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Orig A. 1979 Apr;243(2-3):226–244. [PubMed] [Google Scholar]
  9. Hamada S., Torii M. Effect of sucrose in culture media on the location of glucosyltransferase of Streptococcus mutans and cell adherence to glass surfaces. Infect Immun. 1978 Jun;20(3):592–599. doi: 10.1128/iai.20.3.592-599.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., Nakajima K., Pyun K. H., Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci U S A. 1985 Aug;82(16):5490–5494. doi: 10.1073/pnas.82.16.5490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986 Nov 6;324(6092):73–76. doi: 10.1038/324073a0. [DOI] [PubMed] [Google Scholar]
  12. Ishizuka I., Yamakawa T. Glycosyl glycerides from Streptococcus hemolyticus strain D-58. J Biochem. 1968 Jul;64(1):13–23. doi: 10.1093/oxfordjournals.jbchem.a128858. [DOI] [PubMed] [Google Scholar]
  13. Keller R., Fischer W., Keist R., Bassetti S. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect Immun. 1992 Sep;60(9):3664–3672. doi: 10.1128/iai.60.9.3664-3672.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Knox K. W., Wicken A. J. Immunological properties of teichoic acids. Bacteriol Rev. 1973 Jun;37(2):215–257. doi: 10.1128/br.37.2.215-257.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Komuro T., Yomota C., Kimura T., Galanos C. Comparison of R- and S-form lipopolysaccharides fractionated from Escherichia coli UKT-B lipopolysaccharide in pyrogen and Limulus tests. FEMS Microbiol Lett. 1989 Jul 1;51(1):79–83. doi: 10.1016/0378-1097(89)90081-5. [DOI] [PubMed] [Google Scholar]
  16. Kotani S. Bacterial cell surface biological response modifiers and their synthetic counterparts. Adv Exp Med Biol. 1992;319:145–164. doi: 10.1007/978-1-4615-3434-1_16. [DOI] [PubMed] [Google Scholar]
  17. Leopold K., Fischer W. Heterogeneity of lipoteichoic acid detected by anion exchange chromatography. Arch Microbiol. 1992;157(5):446–450. doi: 10.1007/BF00249103. [DOI] [PubMed] [Google Scholar]
  18. Leopold K., Fischer W. Separation of the poly(glycerophosphate) lipoteichoic acids of Enterococcus faecalis Kiel 27738, Enterococcus hirae ATCC 9790 and Leuconostoc mesenteroides DSM 20343 into molecular species by affinity chromatography on concanavalin A. Eur J Biochem. 1991 Mar 14;196(2):475–482. doi: 10.1111/j.1432-1033.1991.tb15839.x. [DOI] [PubMed] [Google Scholar]
  19. MCCARTY M. THE ROLE OF D-ALANINE IN THE SEROLOGICAL SPECIFICITY OF GROUP A STREPTOCOCCAL GLYCEROL TEICHOIC ACID. Proc Natl Acad Sci U S A. 1964 Aug;52:259–265. doi: 10.1073/pnas.52.2.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Matsuda T., Hirano T., Kishimoto T. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies. Eur J Immunol. 1988 Jun;18(6):951–956. doi: 10.1002/eji.1830180618. [DOI] [PubMed] [Google Scholar]
  21. Obayashi T., Tamura H., Tanaka S., Ohki M., Takahashi S., Arai M., Masuda M., Kawai T. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta. 1985 Jun 30;149(1):55–65. doi: 10.1016/0009-8981(85)90273-6. [DOI] [PubMed] [Google Scholar]
  22. Okamoto M., Kaji R., Kasetani H., Yoshida H., Moriya Y., Saito M., Sato M. Purification and characterization of interferon-gamma-inducing molecule of OK-432, a penicillin-killed streptococcal preparation, by monoclonal antibody neutralizing interferon-gamma-inducing activity of OK-432. J Immunother Emphasis Tumor Immunol. 1993 May 4;13(4):232–242. doi: 10.1097/00002371-199305000-00002. [DOI] [PubMed] [Google Scholar]
  23. Sato M., Kaji R., Urata M., Yoshida H., Yanagawa T., Miyamoto K., Azuma M., Furumoto N., Saito M. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and macrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432. J Biol Response Mod. 1988 Apr;7(2):212–228. [PubMed] [Google Scholar]
  24. Takada H., Kawabata Y., Tamura M., Matsushita K., Igarashi H., Ohkuni H., Todome Y., Uchiyama T., Kotani S. Cytokine induction by extracellular products of oral viridans group streptococci. Infect Immun. 1993 Dec;61(12):5252–5260. doi: 10.1128/iai.61.12.5252-5260.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Torello L. A., Yates A. J., Thompson D. K. Critical study of the alditol acetate method for quantitating small quantities of hexoses and hexosamines in gangliosides. J Chromatogr. 1980 Dec 19;202(2):195–209. doi: 10.1016/s0021-9673(00)81728-8. [DOI] [PubMed] [Google Scholar]
  26. Tsutsui O., Kokeguchi S., Matsumura T., Kato K. Relationship of the chemical structure and immunobiological activities of lipoteichoic acid from Streptococcus faecalis (Enterococcus hirae) ATCC 9790. FEMS Microbiol Immunol. 1991 Aug;3(4):211–218. doi: 10.1111/j.1574-6968.1991.tb04217.x. [DOI] [PubMed] [Google Scholar]
  27. Usami H., Yamamoto A., Sugawara Y., Hamada S., Yamamoto T., Kato K., Kokeguchi S., Takada H., Kotani S. A nontoxic tumour necrosis factor induced by streptococcal lipoteichoic acids. Br J Cancer. 1987 Dec;56(6):797–799. doi: 10.1038/bjc.1987.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Usami H., Yamamoto A., Yamashita W., Sugawara Y., Hamada S., Yamamoto T., Kato K., Kokeguchi S., Ohokuni H., Kotani S. Antitumour effects of streptococcal lipoteichoic acids on Meth A fibrosarcoma. Br J Cancer. 1988 Jan;57(1):70–73. doi: 10.1038/bjc.1988.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wicken A. J., Knox K. W. Lipoteichoic acids: a new class of bacterial antigen. Science. 1975 Mar 28;187(4182):1161–1167. doi: 10.1126/science.46620. [DOI] [PubMed] [Google Scholar]
  30. Yamamoto A., Usami H., Nagamuta M., Sugawara Y., Hamada S., Yamamoto T., Kato K., Kokeguchi S., Kotani S. The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis. Br J Cancer. 1985 May;51(5):739–742. doi: 10.1038/bjc.1985.112. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES